Annual progress reports

All eligible countries are invited to submit proposals for Gavi support. 

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

HSS evaluation

The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).

HSS tracking study

The HSS tracking study was undertaken as a complementary more in depth country perspective that helped highlight implementation issues in six countries.

The joint appraisal report and Multi-Stakeholder Dialogue

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.